Open AccessAntenatal Antidepressant Prescription Associated With Reduced Fetal Femur Length but Not Estimated Fetal Weight
Author(s) -
Georgios Schoretsanitis,
Sara V. Carlini,
Majnu John,
John M. Kane,
Kristina M. Deligiannidis
Publication year - 2021
Publication title -
journal of clinical psychopharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.786
H-Index - 121
eISSN - 1533-712X
pISSN - 0271-0749
DOI - 10.1097/jcp.0000000000001446
Subject(s) - medicine , oligohydramnios , obstetrics , medical prescription , gestational age , antidepressant , polyhydramnios , retrospective cohort study , pregnancy , fetus , genetics , hippocampus , pharmacology , biology
Antidepressants are among the most frequently prescribed medications during pregnancy and may affect fetal weight. Associations between antenatal antidepressant use and ultrasonographic measures of fetal development have rarely been examined. We hypothesized that the prescription of an antenatal antidepressant would be associated with lower estimated fetal weight (EFW).